Burcon NutraScience Corporation
BRCNF · OTC
3/31/2025 | 3/31/2024 | 3/31/2023 | 3/31/2022 | |
|---|---|---|---|---|
| Revenue | $381 | $184 | $364 | $171 |
| % Growth | 106.9% | -49.3% | 112.2% | – |
| Cost of Goods Sold | $1,252 | $0 | $0 | $0 |
| Gross Profit | -$871 | $184 | $364 | $171 |
| % Margin | -228.3% | 100% | 100% | 100% |
| R&D Expenses | $3,475 | $4,033 | $4,125 | $3,293 |
| G&A Expenses | $3,780 | $3,625 | $3,733 | $4,198 |
| SG&A Expenses | $3,905 | $3,742 | $3,733 | $5,646 |
| Sales & Mktg Exp. | $125 | $118 | $0 | $1,448 |
| Other Operating Expenses | -$551 | -$571 | $31 | -$1,370 |
| Operating Expenses | $6,829 | $7,203 | $7,889 | $7,569 |
| Operating Income | -$7,699 | -$7,019 | -$7,525 | -$7,398 |
| % Margin | -2,018.8% | -3,807.2% | -2,067.9% | -4,314.2% |
| Other Income/Exp. Net | -$565 | -$427 | -$17,839 | -$2,888 |
| Pre-Tax Income | -$8,265 | -$7,446 | -$25,364 | -$10,285 |
| Tax Expense | $0 | $0 | $0 | -$27 |
| Net Income | -$8,265 | -$7,446 | -$25,364 | -$10,258 |
| % Margin | -2,167% | -4,039% | -6,969.9% | -5,982.6% |
| EPS | -1.06 | -0.061 | -0.23 | -0.095 |
| % Growth | -1,629.2% | 73.3% | -143.4% | – |
| EPS Diluted | -1.06 | -0.061 | -0.23 | -0.095 |
| Weighted Avg Shares Out | 7,820 | 121,400 | 108,729 | 108,588 |
| Weighted Avg Shares Out Dil | 7,820 | 121,398 | 108,729 | 108,588 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $88 | $425 | $434 |
| Interest Expense | $552 | $512 | $466 | $113 |
| Depreciation & Amortization | $265 | $279 | $239 | $156 |
| EBITDA | -$7,435 | -$6,740 | -$7,286 | -$7,582 |
| % Margin | -1,949.3% | -3,655.7% | -2,002.1% | -4,421.6% |